Robert Half (RHI)

NYSEIndustrialsStaffing & Employment ServicesSnapshot 2026-10-23

$45.87+21.74%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Robert Half’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.6%

+10% or more+5%0%−5%−10% or less

1.97 → 1.98 EPS · FY ending Dec 31, 2027 · 6 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 6; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	1.34B
EPS	—	0.41
Annual ending 2026-12-31
Revenue	—	5.33B
EPS	—	1.306
Annual ending 2027-12-31
Revenue	—	5.54B
EPS	—	1.983

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain dividend payments at $0.59 per share	Robert Half keeps paying a steady dividend of $0.59 per share.	Intact	Dividend per share falls below $0.59 in next 4 quarters	Dividend per share: $0.59 per share FY2026-Q2; GAAP. Published target: >=0.59 USD_PER_SHARE. Target period is not explicitly aligned with this observation. Source published Aug 4, 20260.59 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cd74d7e8-f1ff-4fc0-ae7a-b3b235850df9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context The supplied transcripts do not state this priority, so quarters_stated is 0; historical_evidence records the latest transcript period without a dividend quote. Financial data reports a $0.59 per-share dividend in 2026-Q2, but there is no management statement in the supplied transcripts tying that payment to a commitment or trajectory. Delivery assessment Oct 24, 2026
Improve cash from operations above $0 in next 4 quarters	Operational cash flow improvement would support a recovery.	Under Pressure	Cash from operations remains negative in next 4 quarters	Cash from operations: $108.698M FY2026-Q2; GAAP. Published target: >0 USD. Target period is not explicitly aligned with this observation. Source published Aug 4, 2026108,698,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth above $5.38 billion in FY2025	The company aims to grow revenue above $5.38 billion in 2025.	Intact	Revenue falls below $5.0 billion in FY2025	Revenue: $1.336B FY2026-Q2; GAAP. Published target: >=5.38 USD_BILLIONS. Target period is not explicitly aligned with this observation. Source published Aug 4, 20261,336,365,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cd74d7e8-f1ff-4fc0-ae7a-b3b235850df9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.98

$2.06 → $1.98 · observed estimates

FY2027 revenue$5.54B

$5.55B → $5.54B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.06	$5,548,815,290	10 / 9
2026-07-25	$1.99	$5,528,273,700	9 / 8
2026-07-26	$1.96	$5,526,050,726	7 / 6
2026-07-27	$1.97	$5,525,998,840	9 / 9
2026-07-28	$1.97	$5,525,998,840	9 / 9
2026-07-29	$1.97	$5,531,776,620	9 / 9
2026-07-30	$1.97	$5,531,828,503	7 / 7
2026-07-31	$1.97	$5,531,828,503	7 / 7
2026-08-01	$1.97	$5,531,828,503	7 / 7
2026-08-02	$1.97	$5,531,776,620	9 / 9
2026-08-03	$1.97	$5,531,776,620	9 / 9
2026-08-04	$1.97	$5,531,776,620	9 / 9
2026-08-05	$1.97	$5,531,828,503	7 / 7
2026-08-06	$1.97	$5,531,828,503	7 / 7
2026-08-08	$1.97	$5,531,776,620	9 / 9
2026-08-09	$1.97	$5,531,828,503	7 / 7
2026-08-10	$1.97	$5,531,776,620	9 / 9
2026-08-12	$1.97	$5,531,776,620	9 / 9
2026-08-13	$1.97	$5,531,776,620	9 / 9
2026-08-14	$1.97	$5,531,828,503	7 / 7
2026-08-15	$1.97	$5,531,828,503	7 / 7
2026-08-16	$1.97	$5,531,828,503	7 / 7
2026-08-17	$1.97	$5,531,828,503	7 / 7
2026-08-18	$1.97	$5,531,828,503	7 / 7
2026-08-19	$1.97	$5,531,828,503	7 / 7
2026-08-20	$1.97	$5,531,828,503	7 / 7
2026-08-21	$1.97	$5,531,826,881	7 / 7
2026-08-22	$1.97	$5,531,826,881	7 / 7
2026-08-23	$1.97	$5,531,826,881	7 / 7
2026-08-24	$1.97	$5,531,826,881	7 / 7
2026-08-25	$1.97	$5,531,826,881	7 / 7
2026-08-26	$1.97	$5,531,826,881	7 / 7
2026-08-27	$1.97	$5,531,826,881	7 / 7
2026-08-28	$1.97	$5,531,826,881	7 / 7
2026-08-29	$1.97	$5,531,826,881	7 / 7
2026-08-30	$1.97	$5,531,826,881	7 / 7
2026-08-31	$1.97	$5,531,826,881	7 / 7
2026-09-01	$1.97	$5,531,826,881	7 / 7
2026-09-02	$1.97	$5,531,826,881	7 / 7
2026-09-03	$1.97	$5,531,826,881	7 / 7
2026-09-04	$1.97	$5,531,826,881	7 / 7
2026-09-05	$1.97	$5,531,826,881	7 / 7
2026-09-06	$1.97	$5,531,826,881	7 / 7
2026-09-07	$1.97	$5,531,826,881	7 / 7
2026-09-08	$1.97	$5,531,826,881	7 / 7
2026-09-09	$1.97	$5,531,826,881	7 / 7
2026-09-10	$1.97	$5,531,826,881	7 / 7
2026-09-11	$1.97	$5,531,826,881	7 / 7
2026-09-12	$1.97	$5,531,826,881	7 / 7
2026-09-13	$1.97	$5,531,826,881	7 / 7
2026-09-14	$1.97	$5,531,826,881	7 / 7
2026-09-15	$1.97	$5,531,826,881	7 / 7
2026-09-16	$1.97	$5,530,158,320	7 / 7
2026-09-17	$1.97	$5,530,158,320	7 / 7
2026-09-18	$1.97	$5,530,158,320	7 / 7
2026-09-19	$1.97	$5,530,158,320	7 / 7
2026-09-20	$1.97	$5,530,158,320	7 / 7
2026-09-21	$1.97	$5,530,158,320	7 / 7
2026-09-22	$1.97	$5,530,158,320	7 / 7
2026-09-23	$1.97	$5,530,158,320	7 / 7
2026-09-24	$1.97	$5,530,158,320	7 / 7
2026-09-25	$1.97	$5,530,158,320	7 / 7
2026-09-26	$1.97	$5,530,158,320	7 / 7
2026-09-27	$1.97	$5,530,158,320	7 / 7
2026-09-28	$1.97	$5,530,158,320	7 / 7
2026-09-29	$1.97	$5,530,158,320	7 / 7
2026-09-30	$1.97	$5,530,158,320	7 / 7
2026-10-01	$1.97	$5,530,158,320	7 / 7
2026-10-02	$1.97	$5,530,158,320	7 / 7
2026-10-03	$1.97	$5,530,158,320	7 / 7
2026-10-04	$1.97	$5,530,158,320	7 / 7
2026-10-05	$1.97	$5,530,158,320	7 / 7
2026-10-06	$1.97	$5,530,158,320	7 / 7
2026-10-07	$1.97	$5,530,158,320	7 / 7
2026-10-08	$1.97	$5,530,158,320	7 / 7
2026-10-09	$1.97	$5,530,158,320	7 / 7
2026-10-10	$1.97	$5,530,158,320	7 / 7
2026-10-11	$1.97	$5,530,158,320	7 / 7
2026-10-12	$1.97	$5,530,158,320	7 / 7
2026-10-13	$1.97	$5,530,158,320	7 / 7
2026-10-14	$1.97	$5,530,158,320	7 / 7
2026-10-15	$1.97	$5,530,158,320	7 / 7
2026-10-16	$1.97	$5,530,158,320	7 / 7
2026-10-17	$1.97	$5,530,158,320	7 / 7
2026-10-18	$1.97	$5,530,158,320	7 / 7
2026-10-19	$1.97	$5,530,158,320	7 / 7
2026-10-20	$1.97	$5,530,158,320	7 / 7
2026-10-21	$1.97	$5,530,158,320	7 / 7
2026-10-22	$1.97	$5,530,158,320	7 / 7
2026-10-23	$1.98	$5,539,285,987	6 / 7
2026-10-24	$1.98	$5,543,821,222	6 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	3	4	4
2026-06-01	3	4	4
2026-07-01	4	4	4
2026-08-01	4	3	4
2026-09-01	4	3	4
2026-10-01	4	3	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 3 Hold · 4 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Robert W. BairdOct 23 · prior Jul 27

$47.00 → $53.00+12.8%

JefferiesOct 23

$33.00New observation · no comparable prior

Goldman SachsOct 23 · prior Jul 24

$29.00 → $33.00+13.8%

$0$29.15$58.30

2 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain dividend payments at $0.59 per shareDividend per share: $0.59 per share
Improve cash from operations above $0 in next 4 quartersPublished status: Under Pressure
Revenue growth above $5.38 billion in FY2025Revenue: $1.336B

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.5%Typical daily move · historical

Downside history

-35.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Robert Half outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

RHI is a cyclical staffing and consulting business whose results depend on demand across its markets. The multi-year view is in a watch state: talent-solutions revenue has begun to recover, but overall performance remains weak and earnings quality is fragile.

What's priced into Robert Half

RHI is valued at a large premium to peers, and the evidence describes that valuation as expensive with an elevated risk of fragile expectations. The expectations gap is unfavorable: the premium is not supported by recent execution, including an earnings miss and a fresh decline in company momentum.

What the fundamentals likely do

Near term, consecutive earnings misses, weak recent performance, and a headwind in the sector raise execution risk; the stated miss probability is low, but the recent record remains a concern. Over the multi-year view, talent solutions show signs of returning to growth, while operating income has fallen year over year and Protiviti revenue declined, so broader recovery is still limited.

What Robert Half hinges on

The thesis hinges on whether talent-solutions growth spreads into a stronger company-wide recovery and whether management improves operating performance and Protiviti results. A guidance cut would add a meaningful negative, while results and guidance from PAYX, KFY, and TNET could signal whether the sector backdrop is improving or weakening.